Mymobility Knee ROM
Completed · NCT06863428
Conditions: Knee Range of Motion
At a glance
- Research payments reported, 2025
- $2,090
- U.S. investigators named
- 1
- Sites paid
- 1
- Planned or actual enrollment
- 41
About the trial
- Sponsor
- Zimmer Biomet
- Dates
- Started 2025-11-21; completion 2026-03-09
- Results posted
- Not yet
This prospective study aims to evaluate the agreement, also referred as concordance, of the mymobilty knee ROM with a clinician's assessment of knee ROM via goniometer.
From ClinicalTrials.gov, last updated 2026-10-15. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Zimmer Biomet Holdings, Inc. reported $2,090 in research payments for this study in 2025 (1 payments).
Products named: Mymobility Platform
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Wcg Irb $2,090
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.